explore -WSS

explore

author：leisure time 2025-10-02 20:47:53 - browse：94421

ANDREW YATES/AFP via Getty Images

In patients with stage 3 lung cancer where a particular genetic mutation is present in the tumor, taking AstraZeneca’s cancer-fighting pill Tagrisso reduced the chance that disease would progress by 84%.

“This will be practice changing as soon as this becomes available,” said David R. Spigel, chief scientific officer of the Sarah Cannon Research Institute at a press conference announcing the results at the annual meeting of the American Society of Clinical Oncology. “This will be how patients are treated wherever they can get access to this drug.”

Spigel but was not involved in the Tagrisso study but has relationships with multiple drugmakers including AstraZeneca.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： FDA clears AI tool for detecting skin cancer

hotspot

WSS

AI generated plenty of interest at JPM but not a lot of trust

AI generated plenty of interest at JPM but not a lot of trust

Study suggests Covid rebound is far more common with Paxlovid than without

Experimental asthma app from Apple and Anthem shows promise

Research misconduct: Proposed new rules face resistance

Type 2 diabetes prevention programs work at large scale: study

explore

explore

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

entertainment

ChatGPT in medicine: STAT answers readers' burning questions

Readout Newsletter: Ozempic panic wanes, Legend x Novartis, etc.

Trump demands the U.S. pay no more for drugs than other countries … again

AI generated plenty of interest at JPM but not a lot of trust

Trump demands the U.S. pay no more for drugs than other countries … again

How state and local governments are sidelining science

Virginia high school admissions case could be legal follow

Ohio still needs to do more to protect the right to abortion

How to save PrEP access — and even expand it

Elizabeth Holmes banned from government health programs

focus

Test for long Covid? Researchers find new clue in blood samples

CVS, Rite Aid closures threaten to worsen pharmacy deserts

Elizabeth Holmes banned from government health programs

Readout Newsletter: Ozempic panic wanes, Legend x Novartis, etc.

CVS, Rite Aid closures threaten to worsen pharmacy deserts

Today's health inequities arise from racist U.S. history, say experts

leisure time

Wikipedia

hotspot

Wikipedia